Glucarpidase -- a carboxypeptidase enzyme that helps break down and remove methotrexate from the body -- was approved by the FDA in 2012 to treat patients with toxic levels of methotrexate in their ...

Oral glucose-lowering medications weren't up to snuff with insulin for gestational diabetes, a randomized clinical trial ...

Long-term Tecfidera use was found to significantly reduce relapse rates and slow disability progression for MS patients in a ...

In the world of drug development, the timing and design of clinical trials can be crucial in getting a new drug to market ...

Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FSE: 8BN) ("Optimi" or the "Company"), a Health Canada-licensed manufacturer of psychedelic pharmaceuticals specializing in natural psilocybin and MDMA, ...

Drs. Flynn, Park, Kovatsis and Jena are physicians and researchers at Harvard Medical School. Dr. Jena is an author of ...